Mechanistic Profile GHRH-Receptor Activation Tesamorelin research peptide binds the GHRH receptor on pituitary somatotrophs, supporting studies of: GH-release mechanisms pulsatile secretion patterns downstream IGF-1 and IGFBP-3 modulation GH/IGF-1 Axis Modulation Research models examine Tesamorelins ability to modulate circulating: growth hormone IGF-1 IGFBP-3 These pathways are central to studies of anabolic signaling , metabolic regulation , and tissue-remodeling biology
Learn more about Alpha-Arbutin Ocimum Sanctum Leaf Extract comes from the Holy Basil plant
Track changes Run a 612 week cycle and photograph progress every 2 weeks for objective tracking
01 Modified IGF-1 Analog 83-amino-acid variant with reduced IGFBP binding and extended functional half-life 02 99% HPLC Purity Every batch verified via high-performance liquid chromatography 03 USA Tested & Verified Third-party analytical testing performed in USA laboratories RESEARCH IGF-1 LR3 Mechanism of Action in Research The IGF-1 LR3 mechanism of action parallels that of native IGF-1 but with enhanced potency due to its reduced IGFBP sequestration
This product is intended exclusively for laboratory research and should be handled according to proper safety protocols
Accelerated-aging syndromes Progerias or accelerated-aging syndromes are partially recapitulated normal aging (Burtner and Kennedy, 2010)